Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Nukleus Office Solutions Ltd (NSE: NUKLEUS), ISIN INE0VYX01018 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
NUKLEUS last traded at ₹185.00, with a 52-week range of ₹153.00 to ₹239.90 (as of 2 Nov 2026).
Shareholding as of Sep 2026: promoters 70.25%, FIIs 0.00%, DIIs 1.68%, mutual funds 0.00%.
EquiSense Score (ECS): 45/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.